Open Low-field Magnetic Resonance Imaging for Target Definition, Dose Calculations and Set-up Verification during Three-dimensional CRT for Glioblastoma Multiforme

Clinical Oncology

Volumn 20, Issue 2, 2008, Pages 157-167

  Weber, D C ^a,b   Wang, H ^b   Albrecht, S ^b   Ozsahin, M ^c   Tkachuk, E ^b   Rouzaud, M ^b   Nouet, P ^b   Dipasquale, G ^b  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Glioblastoma; interobserver variability; low field MRI; radiation therapy planning

Indexed keywords

ANTINEOPLASTIC AGENT; TEMOZOLOMIDE;

ACCURACY; ADJUVANT THERAPY; ARTICLE; BRAIN BIOPSY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMULATION; TREATMENT PLANNING; TUMOR VOLUME;

BODY BURDEN; FEASIBILITY STUDIES; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38849208328     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.09.001     Document Type: Article

References (32)

1. Krempien R.C., Schubert K., Zierhut D., et al. Open low-field magnetic resonance imaging in radiation therapy treatment planning. Int J Radiat Oncol Biol Phys 53 (2002) 1350-1360
2. Thornton Jr. A.F., Sandler H.M., Ten Haken R.K., et al. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Radiat Oncol Biol Phys 24 (1992) 767-775
3. Just M., Rosler H.P., Higer H.P., et al. MRI-assisted radiation therapy planning of brain tumors-clinical experiences in 17 patients. Magn Reson Imaging 9 (1991) 173-177
4. Aoyama H., Shirato H., Nishioka T., et al. Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. Int J Radiat Oncol Biol Phys 50 (2001) 821-827
5. Khoo V.S., Adams E.J., Saran F., et al. A comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas. Int J Radiat Oncol Biol Phys 46 (2000) 1309-1317
6. Chen L., Price Jr. R.A., Wang L., et al. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys 60 (2004) 636-647
7. McKenna W.G., Yeakel K., Klink A., et al. Is correction for lung density in radiotherapy treatment planning necessary?. Int J Radiat Oncol Biol Phys 13 (1987) 273-278
8. Mah K., and Van Dyk J. On the impact of tissue inhomogeneity corrections in clinical thoracic radiation therapy. Int J Radiat Oncol Biol Phys 21 (1991) 1257-1267
9. Orton C.G., Chungbin S., Klein E.E., et al. Study of lung density corrections in a clinical trial (RTOG 88-08). Int J Radiat Oncol Biol Phys 41 (1998) 787-794
10. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
11. Mah D., Freedman G., Milestone B., et al. Measurement of intrafractional prostate motion using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 54 (2002) 568-575
12. International Commission on Radiation Units and Measurement. Dose specification for reporting external beam therapy with photons and electrons. ICRU Report 50/62 (1993), International Commission on Radiation Units and Measurements, Washington, DC
13. Thomas S.J. A modified power-law formula for inhomogeneity corrections in beams of high-energy X rays. Med Phys 18 (1991) 719-723
14. Myrianthopoulos L.C., Vijayakumar S., Spelbring D.R., et al. Quantitation of treatment volumes from CT and MRI in high-grade gliomas: implications for radiotherapy. Magn Reson Imaging 10 (1992) 375-383
15. Leunens G., Menten J., Weltens C., et al. Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. Radiother Oncol 29 (1993) 169-175
16. Lattanzi J.P., Fein D.A., McNeeley S.W., et al. Computed tomography-magnetic resonance image fusion: a clinical evaluation of an innovative approach for improved tumor localization in primary central nervous system lesions. Radiat Oncol Investig 5 (1997) 195-205
17. Schupak K., Malkin M., Anderson L., et al. The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence. Int J Radiat Oncol Biol Phys 32 (1995) 1167-1176
18. Wallner K.E., Galicich J.H., Krol G., et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16 (1989) 1405-1409
19. Hess C.F., Schaaf J.C., Kortmann R.D., et al. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 30 (1994) 146-149
20. Garden A.S., Maor M.H., Yung W.K., et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 20 (1991) 99-110
21. Nakagawa K., Aoki Y., Fujimaki T., et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40 (1998) 1141-1149
22. Chan J.L., Lee S.W., Fraass B.A., et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20 (2002) 1635-1642
23. Sneed P.K., Gutin P.H., Larson D.A., et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 29 (1994) 719-727
24. Chang J., Thakur S., Perera G., et al. Image-fusion of MR spectroscopic images for treatment planning of gliomas. Med Phys 33 (2006) 32-40
25. Pirzkall A., McKnight T.R., Graves E.E., et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50 (2001) 915-928
26. Douglas J.G., Stelzer K.J., Mankoff D.A., et al. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 64 (2006) 886-891
27. Tralins K.S., Douglas J.G., Stelzer K.J., et al. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. J Nucl Med 43 (2002) 1667-1673
28. Grosu A.-L., Weber W.A., Riedel E., et al. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 64-74
29. Cattaneo G.M., Reni M., Rizzo G., et al. Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans. Radiother Oncol 75 (2005) 217-223
30. Weltens C., Menten J., Feron M., et al. Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother Oncol 60 (2001) 49-59
31. Chen L., Price Jr. R.A., Nguyen T.B., et al. Dosimetric evaluation of MRI-based treatment planning for prostate cancer. Phys Med Biol 49 (2004) 5157-5170
32. Littmann A., Guehring J., Buechel C., et al. Acquisition-related morphological variability in structural MRI. Acad Radiol 13 (2006) 1055-1061